You are here: Industry Insights > Mundipharma

News List

Mundipharma to bring world's first gene therapy for knee osteoarthritis biospectrum
November 20, 2018
Mundipharma will be responsible for the development, marketing and distribution of Invossa to medical professionals and hospitals in Japan.
Mundipharma acquires rights for Invossa osteoarthritis therapy in Japan pharmaceutical-technology
November 19, 2018
Mundipharma has signed a multi-year agreement for up to $600m with Kolon Life Sciences to secure the exclusive rights for Invossa osteoarthritis therapy in Japan.
flutiform Receives Positive Opinion in Europe americanpharmaceuticalreview
November 10, 2018
flutiform has been available in Europe for the treatment of asthma in adults and adolescents (≥12 years old) since 2012 and has a tolerability profile supported by extensive clinical evidence and real-world use for six years across Europe and Asia-Pacific
Mundipharma, Novartis to distribute pain medicine in SE Asia biospectrumasia
September 29, 2018
Novartis will retain all international development responsibility, as well as clinical development activities.
Mundipharma, Novartis to distribute pain medicine in SE Asia biospectrum
September 12, 2018
Novartis will retain all international development responsibility, as well as clinical development activities.
Mundipharma gets global rights to market digestive health supplement biospectrumasia
September 07, 2018
Zyactinase™ is a freeze-dried extract of Kiwifruit (Actinidia deliciosa) that has been developed as a constipation relief product as well as for long-term gut health
Mundipharma to launch Cold Defence in Turkey and Canada biospectrumasia
August 28, 2018
Cold Defence™ is a natural product with anti-viral effects that helps to eliminate 99% of cold and flu viruses and shorten the duration of common colds
Mundipharma's painfocus set to transform pain management via AI biospectrumasia
August 08, 2018
painfocus™ uses advanced machine learning that combines multiple physiology biomarkers captured using wearable devices to calculate the presence and severity of pain
PharmaJet, Mundipharma unite to expand needle-free technology worldwide biospectrumasia
July 26, 2018
An exclusive partnership for the multinational healthcare organization to market and distribute PharmaJet's Tropis® and Stratis® needle-free devices across more than 120 markets worldwide
Neovii, Mundipharma enter strategic collaboration biospectrumasia
July 09, 2018
Grafalon is the recognised standard of care in leading transplant centres.

Previous page 1 2 3 4 5 6 Next page